Summary
A one compartment open model has been found to fit plasma concentration data previously obtained in man after single oral doses of alclofenac; the parameters of the model are:\({\text{t}}_{\tfrac{{\text{1}}}{{\text{2}}}} \) abs=1.3±0.7h,\({\text{t}}_{\tfrac{{\text{1}}}{{\text{2}}}} \) el=3.5±1.2h, Vd/F=17±6. The model has been used successfully to predict steady-state plasma levels of alclofenac after multiple oral doses. One treatment schedule (initial dose 500 mg, maintenance dose 250 mg five times a day) was administered to two volunteers for five days and the plasma levels of alclofenac determined daily. The latter were in good agreement with computer predictions based on the model. It is now possible, therefore, to select the most suitable dosage regimes for this drug.
Similar content being viewed by others
References
Roncucci, R., Simon, M.-J., Lambelin, G., Staquet, M., Gillet, C., Van Cauwenberge, H., Lefebvre, P., Daubresse, J.C., Buu-Hoi, N.P.: Europ. J. clin. Pharmacol.3, 176–181 (1971)
Roncucci, R., Simon, M.-J., Lambelin, G.: J. Chromatogr.62, 135–137 (1971)
Roncucci, R., Simon, M.-J., Gillet, C., Lambelin, G., Kaisin, M.: Proceedings of the international symposium on gas chromatography mass spectrometry. Isle of Elba, 1972, 423–449. (Ed. A. Frigerio) Milano: Tamburini Editore 1972
Krüger-Thiemer, E.: J. theoret. Biol.13, 212–235 (1966)
Wagner, J.G.: Biopharmaceutics and relevant pharmacokinetics. Hamilton, Ill.: Drug Intelligence Pub. 1971
Roncucci, R.: personal observations (1971)
Author information
Authors and Affiliations
Additional information
Mervan®, Continental Pharma S.A., Brussels, Belgium
Rights and permissions
About this article
Cite this article
Strolin Benedetti, M., Strolin, P., Roncucci, R. et al. Evaluation of alclofenac treatment regimes in man. Eur J Clin Pharmacol 6, 261–267 (1973). https://doi.org/10.1007/BF00644743
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00644743